Refractory Diffuse Intrinsic Pontine Glioma
4 clinical trials · Condition
◉ Watch Refractory Diffuse Intrinsic Pontine Glioma
| Record | Firm | Date |
|---|---|---|
| Savolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors (NCT03598244) | National Cancer Institute (NCI) | 2018-11-27 |
| Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors (NCT03387020) | Pediatric Brain Tumor Consortium | 2018-01-13 |
| Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma (NCT02359565) | National Cancer Institute (NCI) | 2015-06-03 |
Track Refractory Diffuse Intrinsic Pontine Glioma automatically
Every clearance here is in the API, with alerts when new ones post.